Patel Chirag N, Kumar Sivakumar Prasanth, Modi Krunal M, Soni Mehul N, Modi Nainesh R, Pandya Himanshu A
Department of Botany, Bioinformatics and Climate Change Impacts Management, University School of Science, Gujarat University , Ahmedabad , India.
Molecular Biophysics Unit, Indian Institute of Science , Bangalore , India.
J Recept Signal Transduct Res. 2019 Jun;39(3):226-234. doi: 10.1080/10799893.2019.1660893. Epub 2019 Sep 11.
Cardiotonic steroids (CTS) are steroidal drugs, processed from the seeds and dried leaves of the genus Digitalis as well as from the skin and parotid gland of amphibians. The most commonly known CTS are ouabain, digoxin, digoxigenin and bufalin. CTS can be used for safer medication of congestive heart failure and other related conditions due to promising pharmacological and medicinal properties. Ouabain isolated from plants is widely utilized in studies to specifically block the sodium potassium (Na/K-ATPase) pump. For checking, whether ouabain derivatives are robust inhibitors of Na/K-ATPase pump, molecular docking simulation was performed between ouabain and its derivatives using YASARA software. The docking energy falls within the range of 8.470 kcal/mol to 7.234 kcal/mol, in which digoxigenin was found to be the potential ligand with the best docking energy of 8.470 kcal/mol. Furthermore, pharmacophore modeling was applied to decipher the electronic features of CTS. Molecular dynamics simulation was also employed to determine the conformational properties of Na/K-ATPase-ouabain and Na/K-ATPase-digoxigenin complexes with the plausible structural integrity through conformational ensembles for 100 ns which promoted digoxigenin as the most promising CTS for treating conditions of congestive heart failure patients.
强心甾类化合物(CTS)是一类甾体药物,可从洋地黄属植物的种子和干叶以及两栖动物的皮肤和腮腺中提取。最常见的CTS有哇巴因、地高辛、洋地黄毒苷元和蟾毒灵。由于具有良好的药理和药用特性,CTS可用于更安全地治疗充血性心力衰竭和其他相关病症。从植物中分离出的哇巴因在研究中被广泛用于特异性阻断钠钾(Na/K-ATPase)泵。为了检验哇巴因衍生物是否是Na/K-ATPase泵的强效抑制剂,使用YASARA软件对哇巴因及其衍生物进行了分子对接模拟。对接能量在8.470 kcal/mol至7.234 kcal/mol范围内,其中洋地黄毒苷元被发现是对接能量最佳的潜在配体,为8.470 kcal/mol。此外,应用药效团模型来解读CTS的电子特征。还采用分子动力学模拟来确定Na/K-ATPase-哇巴因和Na/K-ATPase-洋地黄毒苷元复合物的构象性质,并通过100 ns的构象集合确定其合理的结构完整性,这使得洋地黄毒苷元成为治疗充血性心力衰竭患者最有前景的CTS。